Page last updated: 2024-08-23

phosphotyrosine and Vascular Malformations

phosphotyrosine has been researched along with Vascular Malformations in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, YW; Huang, YH; Pan, SC; Su, WC; Wu, LW; Wu, MP	1

Other Studies

1 other study(ies) available for phosphotyrosine and Vascular Malformations

Article	Year
STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production. Angiogenesis, 2013, Volume: 16, Issue:1 Topics: Base Sequence; Cell Movement; Cell Nucleus; Endothelial Cells; Fibroblast Growth Factor 2; Human Umbilical Vein Endothelial Cells; Humans; Molecular Sequence Data; Mutation, Missense; Myocytes, Smooth Muscle; Neovascularization, Physiologic; Neutralization Tests; Phosphorylation; Phosphotyrosine; Promoter Regions, Genetic; Protein Binding; Protein Transport; Receptor, TIE-2; STAT1 Transcription Factor; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A; Vascular Malformations	2013

Article

Year

STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.

Angiogenesis, 2013, Volume: 16, Issue:1

Topics: Base Sequence; Cell Movement; Cell Nucleus; Endothelial Cells; Fibroblast Growth Factor 2; Human Umbilical Vein Endothelial Cells; Humans; Molecular Sequence Data; Mutation, Missense; Myocytes, Smooth Muscle; Neovascularization, Physiologic; Neutralization Tests; Phosphorylation; Phosphotyrosine; Promoter Regions, Genetic; Protein Binding; Protein Transport; Receptor, TIE-2; STAT1 Transcription Factor; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A; Vascular Malformations

2013